Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.64 |
| ▸ | ESR1 | P03372 | 2/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.46 |
| ▸ | BCL2 | P10415 | 1/20 | 0.42 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | FNTA | P49354 | 1/20 | 0.39 |
| ▸ | FNTB | P49356 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL29152301 | 0.98 | KEAP1 (0.62) | KEAP1ESR1ESR2ALOX5BCL2 | |
| SCHEMBL8656644 | 0.84 | KEAP1 (0.78) | KEAP1ESR1ESR2ALOX5BCL2 | |
| SCHEMBL21380600 | 0.83 | KEAP1 (0.42) | KEAP1BCL2BCL2L1 | |
| SCHEMBL352619 | 0.82 | CALM1 (0.52) | ALOX5BCL2BCL2L1MEN1KMT2A | |
| SCHEMBL17415872 | 0.80 | CALM1 (0.50) | ALOX5BCL2BCL2L1MEN1KMT2A | |
| SCHEMBL28039804 | 0.80 | CALM1 (0.50) | ALOX5BCL2BCL2L1MEN1KMT2A | |
| SCHEMBL28040183 | 0.80 | CALM1 (0.50) | ALOX5BCL2BCL2L1MEN1KMT2A | |
| SCHEMBL4456400 | 0.79 | MEN1 (0.43) | KEAP1MEN1MAPTKMT2A | |
| SCHEMBL29057972 | 0.79 | IDO1 (0.43) | KEAP1MAPT | |
| SCHEMBL21669269 | 0.79 | KEAP1 (0.39) | KEAP1BCL2BCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119039723-B | Preparation method and application of aqueous polyvinyl chloride emulsion and functional film | 中建国际工程有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-118454733-A | Carbon-supported electron-rich phenolic resin electrocatalyst and preparation method thereof | 武汉纺织大学 | 2024-08-09 | — | — | CN | claimed |
| CN-118389104-A | High-temperature-resistant toughening adhesive and preparation method thereof | 宁夏嘉铂睿环保科技集团有限公司 | 2024-07-26 | — | — | CN | claimed |
| CN-116339083-A | Thick photoresist cleaning solution | 安集微电子科技（上海）股份有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-122073954-A | Flexible thermoelectric device and preparation method thereof | 西安热工研究院有限公司 | 2026-05-22 | — | — | CN | disclosed |
| CN-119876994-A | Copper-based electrocatalytic material and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-118164997-B | Sesquiterpene lactone scaberol C thioether derivative, and preparation method and application thereof | 沈阳药科大学 | 2025-02-11 | — | — | CN | disclosed |
| CN-109721640-B | Caspofungin intermediate and synthesis method thereof | 鲁南制药集团股份有限公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-119145230-A | Preparation method of compliant skin care fabric | 邵建平 | 2024-12-17 | — | — | CN | disclosed |
| CN-114685330-B | Process for producing thio-ethylene compound | 华南理工大学 | 2024-09-10 | — | — | CN | disclosed |
| CN-118454733-A | Carbon-supported electron-rich phenolic resin electrocatalyst and preparation method thereof | 武汉纺织大学 | 2024-08-09 | — | — | CN | disclosed |
| CN-118164997-A | Sesquiterpene lactone scaberol C thioether derivative, and preparation method and application thereof | 沈阳药科大学 | 2024-06-11 | — | — | CN | disclosed |
| US-7807713-B2 | Pan-antagonists for the androgen receptor and androgen associated with anti-androgen withdrawal | UNIVERSITY OF DELAWARE (US) | 2010-10-05 | — | — | US | disclosed |
| US-20090270512-A1 | Pan-Antagonists For The Androgen Receptor And Androgen Receptor Mutants Associated With Anti-Androgen Withdrawal | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-10-29 | — | — | US | disclosed |
| US-20090270512-A1 | Pan-Antagonists For The Androgen Receptor And Androgen Receptor Mutants Associated With Anti-Androgen Withdrawal | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-10-29 | — | — | US | disclosed |
| US-7550505-B2 | Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal | UNIVERSITY OF DELAWARE (US) | 2009-06-23 | — | — | US | disclosed |
| US-7550505-B2 | Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal | UNIVERSITY OF DELAWARE (US) | 2009-06-23 | — | — | US | disclosed |
| US-20080064757-A1 | Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-03-13 | — | — | US | disclosed |
| US-20080064757-A1 | Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-03-13 | — | — | US | disclosed |
| WO-2008013791-A2 | PAN-ANTAGONISTS FOR THE ANDROGEN RECEPTOR AND ANDROGEN RECEPTOR MUTANTS ASSOCIATED WITH ANTI-ANDROGEN WITHDRAWAL | UNIVERSITY OF DELAWARE (US) | 2008-01-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090270512-A1 | Pan-Antagonists For The Androgen Receptor And Androgen Receptor Mutants Associated With Anti-Androgen Withdrawal | AR, NR5A1, SHBG | KEAP1 4132/4885ESR1 94/4885ESR2 29/4885 |
| US-20080064757-A1 | Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal | AR, NR5A1, SHBG | KEAP1 4132/4885ESR1 94/4885ESR2 29/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.